These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 19121088

  • 1. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
    Miyazawa M, Yasuda M, Fujita M, Kajiwara H, Hirabayashi K, Takekoshi S, Hirasawa T, Murakami M, Ogane N, Kiguchi K, Ishiwata I, Mikami M, Osamura RY.
    Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
    [Abstract] [Full Text] [Related]

  • 2. Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway.
    Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, Muramatsu T, Miyazaki S, Harasawa M, Matsui N, Ogane N, Murakami M, Mikami M, Yanase T, Osamura RY.
    J Obstet Gynaecol Res; 2010 Apr; 36(2):448-53. PubMed ID: 20492406
    [Abstract] [Full Text] [Related]

  • 3. Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
    Verheul HM, Salumbides B, Van Erp K, Hammers H, Qian DZ, Sanni T, Atadja P, Pili R.
    Clin Cancer Res; 2008 Jun 01; 14(11):3589-97. PubMed ID: 18519793
    [Abstract] [Full Text] [Related]

  • 4. Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling.
    Wang Y, Zhao Q, Ma S, Yang F, Gong Y, Ke C.
    IUBMB Life; 2007 Nov 01; 59(11):717-21. PubMed ID: 17968710
    [Abstract] [Full Text] [Related]

  • 5. [Relationship of hypoxia-inducible factor-1alpha expression and vascular endothelial growth factor in SKOV-3 ovarian cancer model].
    Jiang HY, Feng YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov 01; 39(11):767-70. PubMed ID: 15634505
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z.
    Anticancer Res; 2008 Nov 01; 28(3A):1659-66. PubMed ID: 18630523
    [Abstract] [Full Text] [Related]

  • 7. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
    Luo J, Peng ZL, Yang KX, Wang H, Yang H, Dong DD, Yao XY.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan 01; 40(1):38-41. PubMed ID: 15774091
    [Abstract] [Full Text] [Related]

  • 8. Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells.
    Zhang Z, Yu D, Yin D, Wang Z.
    Anim Reprod Sci; 2011 May 01; 125(1-4):42-8. PubMed ID: 21477953
    [Abstract] [Full Text] [Related]

  • 9. [Inhibition of hypoxia-inducible factor 1alpha expression and tumor growth in SKOV3 ovarian cancer model by sirolimus].
    Jiang HY, Feng YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul 01; 39(7):474-7. PubMed ID: 15347472
    [Abstract] [Full Text] [Related]

  • 10. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P, Mateo J.
    Oncogene; 2009 Jan 22; 28(3):313-24. PubMed ID: 18978810
    [Abstract] [Full Text] [Related]

  • 11. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM, Li DC, Zhang ZX, Zhang XY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2258-64. PubMed ID: 19080330
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
    Naruse T, Kawasaki G, Yanamoto S, Mizuno A, Umeda M.
    Anticancer Res; 2011 Dec 20; 31(12):4429-37. PubMed ID: 22199311
    [Abstract] [Full Text] [Related]

  • 13. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X, Jin HR, Lee D, Lee JH, Kim SK, Lee JJ.
    Eur J Pharmacol; 2008 Sep 11; 592(1-3):41-7. PubMed ID: 18639543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxia-inducible factor-1alpha in the developing rat brain after hypoxia-ischemia.
    Li L, Qu Y, Mao M, Xiong Y, Mu D.
    Brain Res; 2008 Mar 04; 1197():152-8. PubMed ID: 18241842
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.
    Chan CM, Ma BB, Hui EP, Wong SC, Mo FK, Leung SF, Kam MK, Chan AT.
    Oral Oncol; 2007 Apr 04; 43(4):373-8. PubMed ID: 16979927
    [Abstract] [Full Text] [Related]

  • 17. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
    Kato M, Yamamoto S, Takano M, Matsubara O, Furuya K.
    Int J Gynecol Pathol; 2012 May 04; 31(3):254-63. PubMed ID: 22498943
    [Abstract] [Full Text] [Related]

  • 18. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
    Böhm A, Aichberger KJ, Mayerhofer M, Herrmann H, Florian S, Krauth MT, Derdak S, Samorapoompichit P, Sonneck K, Vales A, Gleixner KV, Pickl WF, Sperr WR, Valent P.
    Eur J Clin Invest; 2009 May 04; 39(5):395-405. PubMed ID: 19320940
    [Abstract] [Full Text] [Related]

  • 19. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
    Shao ZQ, Zheng SB, Xiao YJ, Tan WL, Chen T, Qi H, Jiang YD, Yu ZC, Zhang HJ.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug 04; 25(8):1034-6. PubMed ID: 16109571
    [Abstract] [Full Text] [Related]

  • 20. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.
    Hirasawa T, Miyazawa M, Yasuda M, Shida M, Ikeda M, Kajiwara H, Matsui N, Fujita M, Muramatsu T, Mikami M.
    Int J Gynecol Cancer; 2013 Sep 04; 23(7):1210-8. PubMed ID: 23899586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.